Cargando…

Symptoms Relevant to Surveillance for Ovarian Cancer

To examine how frequently and confidently healthy women report symptoms during surveillance for ovarian cancer. A symptoms questionnaire was administered to 24,526 women over multiple visits accounting for 70,734 reports. A query of reported confidence was included as a confidence score (CS). Chi sq...

Descripción completa

Detalles Bibliográficos
Autores principales: Ore, Robert M., Baldwin, Lauren, Woolum, Dylan, Elliott, Erika, Wijers, Christiaan, Chen, Chieh-Yu, Miller, Rachel W., DeSimone, Christopher P., Ueland, Frederick R., Kryscio, Richard J., van Nagell, John R., Pavlik, Edward J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373027/
https://www.ncbi.nlm.nih.gov/pubmed/28335512
http://dx.doi.org/10.3390/diagnostics7010018
_version_ 1782518740738375680
author Ore, Robert M.
Baldwin, Lauren
Woolum, Dylan
Elliott, Erika
Wijers, Christiaan
Chen, Chieh-Yu
Miller, Rachel W.
DeSimone, Christopher P.
Ueland, Frederick R.
Kryscio, Richard J.
van Nagell, John R.
Pavlik, Edward J.
author_facet Ore, Robert M.
Baldwin, Lauren
Woolum, Dylan
Elliott, Erika
Wijers, Christiaan
Chen, Chieh-Yu
Miller, Rachel W.
DeSimone, Christopher P.
Ueland, Frederick R.
Kryscio, Richard J.
van Nagell, John R.
Pavlik, Edward J.
author_sort Ore, Robert M.
collection PubMed
description To examine how frequently and confidently healthy women report symptoms during surveillance for ovarian cancer. A symptoms questionnaire was administered to 24,526 women over multiple visits accounting for 70,734 reports. A query of reported confidence was included as a confidence score (CS). Chi square, McNemars test, ANOVA and multivariate analyses were performed. 17,623 women completed the symptoms questionnaire more than one time and >9500 women completed it more than one four times for >43,000 serially completed questionnaires. Reporting ovarian cancer symptoms was ~245 higher than ovarian cancer incidence. The positive predictive value (0.073%) for identifying ovarian cancer based on symptoms alone would predict one malignancy for 1368 cases taken to surgery due to reported symptoms. Confidence on the first questionnaire (83.3%) decreased to 74% when more than five questionnaires were completed. Age-related decreases in confidence were significant (p < 0.0001). Women reporting at least one symptom expressed more confidence (41,984/52,379 = 80.2%) than women reporting no symptoms (11,882/18,355 = 64.7%), p < 0.0001. Confidence was unrelated to history of hormone replacement therapy or abnormal ultrasound findings (p = 0.30 and 0.89). The frequency of symptoms relevant to ovarian cancer was much higher than the occurrence of ovarian cancer. Approximately 80.1% of women expressed confidence in what they reported.
format Online
Article
Text
id pubmed-5373027
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-53730272017-04-05 Symptoms Relevant to Surveillance for Ovarian Cancer Ore, Robert M. Baldwin, Lauren Woolum, Dylan Elliott, Erika Wijers, Christiaan Chen, Chieh-Yu Miller, Rachel W. DeSimone, Christopher P. Ueland, Frederick R. Kryscio, Richard J. van Nagell, John R. Pavlik, Edward J. Diagnostics (Basel) Article To examine how frequently and confidently healthy women report symptoms during surveillance for ovarian cancer. A symptoms questionnaire was administered to 24,526 women over multiple visits accounting for 70,734 reports. A query of reported confidence was included as a confidence score (CS). Chi square, McNemars test, ANOVA and multivariate analyses were performed. 17,623 women completed the symptoms questionnaire more than one time and >9500 women completed it more than one four times for >43,000 serially completed questionnaires. Reporting ovarian cancer symptoms was ~245 higher than ovarian cancer incidence. The positive predictive value (0.073%) for identifying ovarian cancer based on symptoms alone would predict one malignancy for 1368 cases taken to surgery due to reported symptoms. Confidence on the first questionnaire (83.3%) decreased to 74% when more than five questionnaires were completed. Age-related decreases in confidence were significant (p < 0.0001). Women reporting at least one symptom expressed more confidence (41,984/52,379 = 80.2%) than women reporting no symptoms (11,882/18,355 = 64.7%), p < 0.0001. Confidence was unrelated to history of hormone replacement therapy or abnormal ultrasound findings (p = 0.30 and 0.89). The frequency of symptoms relevant to ovarian cancer was much higher than the occurrence of ovarian cancer. Approximately 80.1% of women expressed confidence in what they reported. MDPI 2017-03-20 /pmc/articles/PMC5373027/ /pubmed/28335512 http://dx.doi.org/10.3390/diagnostics7010018 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ore, Robert M.
Baldwin, Lauren
Woolum, Dylan
Elliott, Erika
Wijers, Christiaan
Chen, Chieh-Yu
Miller, Rachel W.
DeSimone, Christopher P.
Ueland, Frederick R.
Kryscio, Richard J.
van Nagell, John R.
Pavlik, Edward J.
Symptoms Relevant to Surveillance for Ovarian Cancer
title Symptoms Relevant to Surveillance for Ovarian Cancer
title_full Symptoms Relevant to Surveillance for Ovarian Cancer
title_fullStr Symptoms Relevant to Surveillance for Ovarian Cancer
title_full_unstemmed Symptoms Relevant to Surveillance for Ovarian Cancer
title_short Symptoms Relevant to Surveillance for Ovarian Cancer
title_sort symptoms relevant to surveillance for ovarian cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373027/
https://www.ncbi.nlm.nih.gov/pubmed/28335512
http://dx.doi.org/10.3390/diagnostics7010018
work_keys_str_mv AT orerobertm symptomsrelevanttosurveillanceforovariancancer
AT baldwinlauren symptomsrelevanttosurveillanceforovariancancer
AT woolumdylan symptomsrelevanttosurveillanceforovariancancer
AT elliotterika symptomsrelevanttosurveillanceforovariancancer
AT wijerschristiaan symptomsrelevanttosurveillanceforovariancancer
AT chenchiehyu symptomsrelevanttosurveillanceforovariancancer
AT millerrachelw symptomsrelevanttosurveillanceforovariancancer
AT desimonechristopherp symptomsrelevanttosurveillanceforovariancancer
AT uelandfrederickr symptomsrelevanttosurveillanceforovariancancer
AT krysciorichardj symptomsrelevanttosurveillanceforovariancancer
AT vannagelljohnr symptomsrelevanttosurveillanceforovariancancer
AT pavlikedwardj symptomsrelevanttosurveillanceforovariancancer